Shanghai Pharmaceuticals Holding Co. Ltd. Class ASSE: 601607

"Shanghai Pharmaceuticals Holding Co., Ltd."Announcement on Approval for Production of Paclitaxel Injection

Sep 29, 2026 · Issued by Shanghai Pharmaceuticals Holding Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Approval for Production of Paclitaxel Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Shanghai Pharmaceuticals Holding Co. Ltd. Class A

"Shanghai Pharmaceuticals Holding Co., Ltd."Announcement on Implementation of Dividend Distribution for the First Half of 2026Sep 11
"Shanghai Pharmaceuticals Holding Co., Ltd."Announcement on Approval for Production of Ruxolitinib Phosphate TabletsSep 1
"Shanghai Pharmaceuticals Holding Co., Ltd."Semi-annual Report for 2026Aug 28
"Shanghai Pharmaceuticals Holding Co., Ltd."Announcement on Resolutions of the 3rd Meeting of the 9th Board of DirectorsAug 25

All Shanghai Pharmaceuticals Holding Co. Ltd. Class A news releases